Med Consumer Watch
Has Anyone Gotten Thyroid Cancer From Mounjaro?
Back to Articles
Safety9 min readApril 5, 2026

Has Anyone Gotten Thyroid Cancer From Mounjaro?

Examining the thyroid cancer warning on tirzepatide medications. What the research shows and who should be concerned.

By Med Consumer Watch Team
Mounjaro carries a black box warning about thyroid C-cell tumors based on animal studies. But has anyone actually developed thyroid cancer from tirzepatide? Here's what the evidence shows.

The Black Box Warning

Why the warning exists: • Rodent studies showed thyroid C-cell tumors with GLP-1 medications • Required for all GLP-1 receptor agonists including tirzepatide • Based on animal data, not human cases • Considered a theoretical risk requiring monitoring

The black box warning is the FDA's strongest warning and indicates potential serious risks.

Human Evidence So Far

What clinical trials and post-market data show: • No confirmed cases of medullary thyroid carcinoma (MTC) attributed to tirzepatide in trials • Millions of patients have used GLP-1 medications • Large observational studies haven't shown increased thyroid cancer rates • Rodent thyroid physiology differs significantly from humans

Who Should Avoid Tirzepatide

The medication is contraindicated if you have:
  • Personal history of medullary thyroid carcinoma (MTC)
  • Family history of MTC
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

If you have a family history of unusual thyroid cancers, discuss this with your doctor before starting any GLP-1 medication.

Monitoring Recommendations

What to watch for: • Lump or swelling in neck • Difficulty swallowing • Hoarseness that doesn't go away • Shortness of breath Report these symptoms promptly to your doctor.

The Bottom Line

While the theoretical risk exists based on animal studies, there's no documented evidence of humans developing thyroid cancer specifically from Mounjaro. However, the medication remains contraindicated for those with personal or family history of MTC or MEN 2. For most people, the benefits likely outweigh this theoretical risk, but discuss your individual situation with your healthcare provider.

Sources & References

  • FDA - Mounjaro Prescribing Information
  • Journal of Clinical Endocrinology - GLP-1 and Thyroid Safety

Medical Disclaimer

This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.

Related Articles

Mounjaro and Thyroid Cancer

Read more

Does Mounjaro Cause Cancer?

Read more
Back to All Articles

Enter to Win a $1,788 CoreAge Rx Gift Card

Enter for a chance to use it toward eligible CoreAge Rx products and services.

The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.

No purchase necessary. Prescription products require provider evaluation and approval. See Official Rules. Official Rules · Gift Card Terms · Privacy Policy · Terms